Abstract
A 64-year-old male patient was diagnosed with rectal gastrointestinal stromal tumor(GIST)by prostate biopsy, because of high PSA. We considered that a radical operation was impossible because the tumor occupied the pelvis, and we suspected prostate invasion. After neoadjuvant chemotherapy(imatinib mesylate 400 mg/day), the tumor size was reduced(90×85 mm→60×50mm), and we could thus perform radical resection. The patient is currently receiving adjuvant chemotherapy (imatinib mesylate 400 mg/day), without recurrence.
Publication types
-
Case Reports
-
English Abstract
-
Review
MeSH terms
-
Antinematodal Agents / therapeutic use*
-
Benzamides / therapeutic use*
-
Gastrointestinal Stromal Tumors / drug therapy*
-
Gastrointestinal Stromal Tumors / pathology
-
Gastrointestinal Stromal Tumors / surgery
-
Humans
-
Imatinib Mesylate
-
Male
-
Middle Aged
-
Neoadjuvant Therapy*
-
Neoplasm Invasiveness
-
Piperazines / therapeutic use*
-
Pyrimidines / therapeutic use*
-
Rectal Neoplasms / drug therapy*
-
Rectal Neoplasms / pathology
-
Rectal Neoplasms / surgery
-
Tomography, X-Ray Computed
Substances
-
Antinematodal Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate